Compare Cardinal Health Inc (CAH) vs Goldman Sachs Group Inc (GS) Price & Performance

Cardinal Health IncTrade

Goldman Sachs Group IncTrade

Price performance (Past 24H)

Key statistics

Cardinal Health Inc vs Goldman Sachs Group Inc — how do they compare? Cardinal Health Inc trades at $240 (market cap $55.88B), while Goldman Sachs Group Inc trades at $1,038.01 (market cap $301.19B). The key difference: Goldman Sachs Group Inc is far larger — about 5.4× Cardinal Health Inc's market cap, and Goldman Sachs Group Inc pays the higher dividend (1.93%). Which is the better fit depends on your goals.

	CAH	GS
Market Cap	$55.88B	$301.19B
Sector	Health	Financials
52-Week High	$240.26	$1.15K
52-Week Low	$146.04	$715.95
Enterprise Value	$59.91B	—
Dividend Yield	0.86%	1.93%
Volume	—	2,592,735

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Cardinal Health Inc

No Aura AI signal available yet.

Goldman Sachs Group Inc

Goldman Sachs (GS) trades at $1,034.41, down 0.5% on the day, with a neutral technical signal. The company shows strong fundamental momentum with three consecutive quarterly EPS beats and revenue growth accelerating to $58.3B in 2025. Analyst consensus is mixed with 40% buy ratings but a $1,160 price target suggesting 12% upside potential. Recent news highlights Goldman's leadership role in major upcoming IPOs including Anthropic, SpaceX, and OpenAI.

The outlook remains positive given Goldman's positioning in the upcoming AI IPO wave and strong investment banking pipeline. Key risks include volatile cash flow patterns with negative operating cash flow in recent periods and market sensitivity to interest rate changes. The stock appears reasonably valued at 16x P/E with 31.7% net margins supporting further upside if earnings momentum continues.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

CAH

Cardinal Health beats Q4 EPS estimates by 20% despite missing revenue targets.Stuart Mooney · 21 hours agoBullish Cardinal Health Q4 revenue up 6%, EPS rises 70%, FY27 EPS guidance raised to $12.40-$12.60PRNewsWire · 1 day agoBullish Cardinal Health declares $0.5158 quarterly dividend payable October 15, 2026PRNewsWire · 1 day agoNeutral View details →

Nvidia leads $500B Wall Street consortium to finance AI infrastructure expansion.24/7 Wall Street · 1 day agoBullish Wall Street giants plan $500B to finance AI infrastructure as a new asset class, says Nvidia CEO.CNBC · 1 day agoBullish Goldman Sachs advises investors to stay invested amid stable rates, AI benefits, and falling oil prices.CNBC · 1 day agoBullish View details →

About Cardinal Health Inc

Cardinal Health is a leading pharmaceutical wholesaler, engaged in the sourcing and distribution of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail-order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and McKesson, the three compose well over 90% of the U.S. pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.

About Goldman Sachs Group Inc

The Goldman Sachs Group, Inc., a bank holding company, is a global investment banking and securities firm specializing in investment banking, trading and principal investments, asset management and securities services. The Company provides services to corporations, financial institutions, governments, and high-net worth individuals.